Sunday, 5 November 2017

Intravascular Ultrasound (IVUS) System offers Quantitative Assessment of Articular Cartilage

Intravascular Ultrasound (IVUS) is an imaging technology that allows seeing coronary arteries from the inside out. This imaging methodology helps find out the amount of atheromatous plaque accumulated in the epicardial coronary vessels. It is particularly useful in conditions where angiography can be unreliable. It is also used to determine the effects of stenosis treatments and results of medical therapy.

IVUS-guided Catheter

Many companies are focusing on the development of innovative products in order to provide customers with a wide range of simplified intravascular ultrasound systems. Royal Philips has announced the re-launch of its Pioneer Plus catheter, the first ever re-entry device featuring IVUS capabilities that help both patients and physicians. It is intended to facilitate catheter positioning and placement in the peripheral vasculature.

This catheter allows doctors to cross the occlusion beyond stenotic lesion before any additional interventional treatment of lesion with the help of interventional methods. According to the company, the this IVUS-guided catheter also helps decrease the overall time of procedure, which enhances the patient comfort level as they spend less time on the operating tables.

Market Overview

Based on the findings of a research report made available by Radiant Insights, Inc.; the global Intravascular Ultrasound System (IVUS) market is likely to register strong growth rate during the forecast period (from 2017 to 2022). Growing cases of cardiovascular diseases (CVDs) are projected to boost the global market over the next few years.

Increased healthcare expenditure in developed regions is also anticipated to augment the demand for IVUS in the forthcoming years. In addition, a popular trend of incorporating intravascular ultrasound systems with other imaging technologies is also predicted to have a positive impact on the overall market growth in near future.

Various clinical studies supporting the use of IVUS guided stent placement are also likely to fuel the market further. Koninklijke Philips N.V.; Terumo Medical Corp. (TMC); Boston Scientific Corp.; Volcano Corp.; Siemens Healthineers; Medtronic Public Ltd. Co.; and Infraredx, Inc. are some of the dominant companies in the global market.

No comments:

Post a Comment